Skip to main content
Erschienen in: BMC Pediatrics 1/2022

Open Access 01.12.2022 | Research article

Evaluation of factors associated the expression of anti-HBs in children in Hunan Province, China

verfasst von: Shan Tan, Shizhou Li, Jianxiang Dong, Hongmei Dai, Minghua Yang, Fang Sun, Yang Yang, Jie Jiang, Shan Zhu, Mingyi Zhao, Zhiheng Chen

Erschienen in: BMC Pediatrics | Ausgabe 1/2022

Abstract

Background and objectives

Vaccine is the most essential avenue to prevent hepatitis B virus (HBV) infection in infants and preschool children in China, with the largest populations carrying HBV in the world. This study aimed to evaluate the factors associating the response level of anti-HBs in children, providing instructions for HBV prevention clinically.

Methods

The children taking physical examinations in the Third Xiangya Hospital from January 2013 to April 2020 were recruited. Telephone follow-up were adopted to collect further information. Univariate logistic regression was used to analyse the relationship between age and anti-HBs expression. Grouping by age and anti-HBs expression, we used chi-square test and T test to compare qualitative and quantitative data between positive group and negative group in each age subgroup. The meaningful variables (P < 0.10) in chi-square test or T test were further assessed with collinearity and chosen for univariate and multivariate logistic regression analysis by the stepwise backward maximum likelihood method (αin = 0.05, αout = 0.10).

Results

A total of 5838 samples (3362 males, 57.6%) were enrolled. In total, the incidence of negative anti-HBs increased with age[OR = 1.037(1.022–1.051)]. Multivariate logistic regression analysis illustrated that anemia[OR = 0.392(0.185–0.835)], age[OR = 2.542(1.961–3.295)] and Vit D[OR = 0.977(0.969–0.984)] in 0.5–2.99 years subgroup, Zinc deficiency[OR = 0.713(0.551–0.923] and age[OR = 1.151(1.028–1.289)] in 3–5.99 years subgroup, Vit D[OR = 0.983(0.971–0.995)] in 12–18 years subgroup had significant association with anti-HBs.

Conclusions

This retrospective study illustrated that age, anemia status, zinc deficiency and vitamin D were associated with anti-HBs expression in specific age groups of children, which could serve as a reference for the prevention of HBV.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12887-022-03718-z.
Shan Tan, Shizhou Li and Jianxiang Dong contributed equally as co-first authors.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HBV
hepatitis B virus
GMT
geometric mean titer
BMI
body mass index

Background

Hepatitis B virus infection has been a worldwide sanitary problem threatening individuals’ health quality. According to a report of World Health Organization, in 2015, the global prevalence of HBV infection in the general population was estimated at 3.5%, nearly 257 million people suffered from chronic HBV infection worldwide and 887,220 persons died of HBV infection [1]. China had the largest citizens carrying HBV. In a study conducted during 2013–2017, the prevalence of HBV infection in the general population of China from 2013 to 2017 was 6.89% (95% CI: 5.84–7.95%), and predicted there were 83,864,139 (95% CI: 60,406,793-110,751,614) infected case in 2018 [2].
HBV transmission happening in the perinatal period and early childhood is an important pattern of transmission [3]. To prevent HBV infection in infants and preschool children and control HBV infection in China, it’s essential to stimulate the hepatitis B vaccination of children. In 2002, the Chinese authority implemented a new vaccine strategy in which vaccines listed in China’s National Immunization Programme, including the hepatitis B vaccine, were offered freely to neonates and infants. All full-term newborns were given hepatitis B vaccine at 0–1-6 month schedule after birth to block transmission from mother to fetus [4, 5], which was consistent with the vaccination schedule recommended by the United States and other developed countries [6]. After this, the hepatitis B vaccine coverage rate increased significantly as the HBsAg prevalence also decreased in China. In a meta-analysis from 2013 to 2017, HBV prevalence in children younger than 15 years old was lower than 2.1% as a result of the HBV immunization scheme for infants [2]. Not coincidentally, an epidemiological survey showed that HBsAg prevalence declined from 10.5 to 0.8% among children < 15 years and 9.9 to 0.3% among children < 5 years during 1992–2014 [7].
Several studies have evaluated the tangible ability to maintain the level of the anti-HBs of the classical pattern of HBV immunization where individuals are injected with the vaccine at 0, 1, and 6 months after birth. First, the time to completion of vaccination is the primary factor. Xiaomei Yue followed the serum anti-HBs levels of Chinese children who received the hepatitis B vaccine as planned. The positive rates of serum anti-HBs(> = 10mIU/ml) were 16,190/17928(90.31%) for 1 year, 10,755/12808(83.95%) for age 2, 6855/9543(71.82%) for age 3, 4997/8042(62.14%) for age 4 [8]. In another study, positive rates of serum anti-HBs for 1–4 years old Chinese children were 79/83(95.3%) for 1 year, 47/53(88.2%) age 2, 44/61(72.1%) for age 3, 82/141(58.2%) for age 4 [9]. The results of the above two studies showed that the positive rate of anti-HBs decreased rapidly during the period from 1 to 3 years old and gradually stabilized after about 4 years old. In addition, the status of maternal immunization [10], large for gestational age [11], dosing schedule [12], vaccinate dosage [13] and mother’s educational background [14] were also reported. However, there is still an immense absence of objective factors influencing the response level associated with the individuals themselves, such as their nutrition condition and the method of birth.
Studies in adults have tested other variables that may affect immune status among those receiving vaccines. Variables have been determined to decrease response levels include the site of injection (the gluteal site of injection decreases its efficiency) [15], obesity [16, 17], cigarette smoking, older age [1517] and the presence of diseases that alter the immune system [17]. No previous studies have conducted a systematic review targeting these variables in children.
In this paper, we evaluate the influence of multiple factors ranging from the detailed objective biochemistry index value to different avenues of birth and feeding on the immunization level of hepatitis B vaccine among children. We also sought to determine the potential co-relationship between different factors affecting that relationship, and provide instruction for hepatitis B prevention clinically.

Methods

Participant recruitment

Children between 6 months and 18 years old attending physical examinations at the Third Xiangya Hospital of Central South University, Changsha, Hunan, between January 2013 and April 2020, were recruited in this study (n = 100,997). Firstly, we eliminated participants who did not undergo anti-HBs detections (n = 56,181) or were detected HBsAg positive (n = 57). Thereafter, we established precise inclusion criteria for the remaining candidates having negative HBsAg (n = 44,759) to generate valid subjects. Herein, participants lacking essential information such as Gender, Age, way of birth, BMI (n = 9180) were not eligible. After which, individuals who were low birth weight (< 2500 g, n = 242), premature (< 37 weeks, n = 430), combined with diseases which might affect the response level of immunization, such as organic disease related to heart, lung, liver and kidney, allergic disease including asthma, anaphylactoid purpura and other immunological diseases (n = 556) were excluded. Next, we filtered subjects failing to follow the obligational hepatitis B vaccination plan, where children would be vaccinated within 24 hours, 1 month, and 6 months (n = 10,887) as well as having revaccination before this physical examination (n = 15,150). Then we obtained further information from mentioned participants (n = 8314), including duration of the lactation period, history of eczema, frequency of cold and exposure to second-hand cigarette smoke by telephone follow-up. Herein, subjects who were unable to provide precise and complete data ascribed to memory bias or loss to follow-up (n = 1206) were eliminated. Then we excluded participants whose mothers had ever been infected with hepatitis B before delivery or given hepatitis B immune globulin at birth (n = 1270). The final candidates (n = 5838) were divided into anti-HBs-positive group (n = 3824) and anti-HBs-negative group (n = 2014). An additional flow chart shown research design in more detail (see Additional file 1). This research was approved by the ethics committee of the Third Xiangya Hospital of Central South University and followed medical ethics. Parental consent in person was achieved for participants under 18 years old.

Statistics reference

The references for statistics were illustrated in Additional file 2 and Additional file 3, including status of anemia, body mass index, level of microelements and the classification standard of anti-HBs. For children younger than 6 years old, growth curve or weight of height is used to evaluate nutrition rather than BMI, whose classification process is cumbersome, so this study will not discuss it. We applied the standard of inhalation of environmental tobacco smoke as the definition of being exposed to SHS [18] and more than 6 colds per year as a definition of frequent colds.

Statistical analysis

Enumeration data were described by n (%). Measurement data meeting the criterion of normal distribution were shown by means and standard deviations. All variables were processed by univariate logistic regression analysis and odds ratios (ORs) and 95% confidence intervals (CIs) were utilized to assess the extent of the relevance. The variables which P value < 0.10 in the chi-square test and T test in any age subgroup were selected for univariate logistic regression analysis, then the variables which P value < 0.10 were selected for further multivariate logistic regression analysis for each age subgroup separately. Scatter plots and fitting lines (loess method, a t-based approximation) were drawn using R language (version 3.6.3) “ggplot2” package. Data were mostly analysed through SPSS (IBM SPSS Statistics for Macintosh, Version 24.0, Armonk, NY: IBM Corp). P < 0.05 was considered statistically significant.

Results

A total of 5838 children were enrolled in this study, including 2476/5838 (42.4%) girls and 3362/5838 (57.6%) boys, among whom there were 2014/5838 (34.5%) anti-HBs-negative children and 3824/5838 (65.5%) anti-HBs-positive children. As mentioned earlier, time to vaccination has a significant impact on vaccine response rates. Therefore, we adopt the univariable logistics regression to analyse the relationship between age and anti-HBs expression. In the whole samples, for each additional year of age, the probability of anti-HBs negative increased by 3.7%[OR = 1.037(1.022–1.051)]. Since age has a great influence on anti-HBs expression, we divided the samples into four subgroups according to the characteristics of children’s development. The 0.5–2.99 years subgroup has 1166 samples, among them, 913/1166(78.3%) samples were anti-HBs positive. The 3–5.99 years subgroup has 1680 samples, among them, 1025/1680(61%) samples were anti-HBs positive. The 6–11.99 years subgroup has 2265 samples, among them, 1407/2265(61.8%) samples were anti-HBs positive. The 12–18 years subgroup has 727 samples, among them, 479/727(65.9%) samples were anti-HBs positive.
Each age subgroup was further divided into the anti-HBs positive group and negative group. The Chi-square test was applied to analyse enumeration data and T test was applied to analyse measurement data conforming to normal distribution between the anti-HBs positive group and negative group. As the result shown in Tables 1 and 2, in the 0.5–2.99 years subgroup, anemia(P < 0.001), age(P < 0.001), WBC(P = 0.011) and Vit D(P < 0.001); in the 3–5.99 years subgroup, zinc deficiency(P = 0.022) and age(P = 0.014); in the 12–18 years subgroup, Vit D(P = 0.012) have significant difference between anti-HBs positive and anti-HBs negative group.
Table 1
Chi-square test results between antibody positive and antibody negative group in four age subgroups
Variable
0.5 ~ 2.99 years(n = 1166)
3 ~ 5.99 years(n = 1680)
6 ~ 11.99 years(n = 2265)
12 ~ 18 years(n = 727)
AntiHBs Expression
P
AntiHBs Expression
P
AntiHBs Expression
P
AntiHBs Expression
P
Positive
(n = 913)
Negative
(n = 253)
Positive
(n = 1025)
Negative
(n = 655)
Positive
(n = 1407)
Negative
(n = 828)
Positive
(n = 479)
Negative
(n = 248)
Gender
 Female
403
119
0.412
432
279
0.856
609
380
0.640
173
81
0.354
 Male
510
134
 
593
376
 
798
478
 
308
167
 
Birth way
 eutocia
422
115
0.829
520
341
0.595
764
453
0.487
247
137
0.347
 cesarean section
491
138
 
505
314
 
643
405
 
232
111
 
BMI
      
 thin
116
66
0.131
54
41
0.133
 normal
1040
665
 
336
162
 
 overweight or obese
251
127
 
89
45
 
Duration of lactation period (month),
 0~
285
82
0.150
328
208
0.875
439
257
0.311
160
86
0.557
 6~
455
111
 
503
319
 
692
449
 
224
121
 
 12~
173
60
 
190
128
 
276
152
 
95
41
 
Whether the children had a history of eczema
 Yes
318
93
0.570
327
225
0.297
443
220
0.253
143
82
0.375
 No
595
160
 
698
430
 
964
568
 
336
166
 
Whether the children had a history of second-hand cigarette exposure
 Yes
259
66
0.474
284
195
0.361
431
233
0.078*
142
72
0.864
 No
654
187
 
741
460
 
976
625
 
337
176
 
Whether the children had a frequent cold
 Yes
214
67
0.317
258
168
0.828
349
203
0.538
114
58
0.901
 No
699
186
 
767
487
 
1058
655
 
365
190
 
Anemia
 Yes
97
8
< 0.001***
85
42
0.155
112
58
0.293
20
10
0.927
 No
816
245
 
940
613
 
1295
800
 
459
238
 
Lead intoxication
 Yes
3
0
0.832
2
2
0.999
8
1
0.097*
4
2
0.968
 No
910
253
 
1023
653
 
1399
857
 
475
248
 
Cadmium intoxication
 Yes
29
14
0.078*
17
12
0.790
35
26
0.439
11
7
0.665
 No
884
239
 
1008
643
 
1372
832
 
468
241
 
Zinc deficiency
 Yes
673
174
0.119
159
130
0.022**
988
632
0.079*
185
112
0.089*
 No
240
79
 
866
525
 
419
226
 
294
136
 
Copper deficiency
 Yes
118
29
0.535
214
161
0.076*
412
264
0.453
177
100
0.375
 No
796
224
 
811
494
 
995
594
 
302
148
 
Calcium deficiency
 Yes
4
2
0.844
35
27
0.453
436
258
0.646
326
153
0.086*
 No
909
251
 
990
628
 
971
600
 
153
95
 
Iron deficiency
 Yes
490
118
0.095*
388
236
0.451
286
176
0.915
28
16
0.745
 No
433
135
 
637
419
 
1121
682
 
451
232
 
*P < 0.10; **P < 0.05; ***P < 0.01
Table 2
T test results between antibody positive and antibody negative group in four age subgroups
Variable
0.5 ~ 2.99 years(n = 1166)
3 ~ 5.99 years(n = 1680)
6 ~ 11.99 years(n = 2265)
12 ~ 18 years(n = 727)
Anti-HBs Expression
(\(\overline{\textrm{X}}\) ±SD)
P
Anti-HBs Expression
(\(\overline{\textrm{X}}\) ±SD)
P
Anti-HBs Expression
(\(\overline{\textrm{X}}\) ±SD)
P
Anti-HBs Expression
(\(\overline{\textrm{X}}\) ±SD)
P
Positive
(n = 913)
Negative
(n = 253)
Positive
(n = 1025)
Negative
(n = 655)
Positive
(n = 1407)
Negative(n = 828)
Positive
(n = 479)
Negative(n = 248)
Age
1.790 ± 0.663
2.129 ± 0.506
< 0.001***
4.291 ± 0.867
4.398 ± 0.879
0.014**
8.781 ± 1.668
8.697 ± 1.700
0.247
13.657 ± 1.226
13.608 ± 1.224
0.610
WBC(10^9/L)
8.596 ± 2.395
8.236 ± 1.857
0.011**
7.659 ± 2.109
7.571 ± 2.064
0.405
6.896 ± 1.950
6.870 ± 1.801
0.746
6.469 ± 1.560
6.487 ± 1.528
0.882
VitD(ng/ml)
48.343 ± 18.992
40.810 ± 17.443
< 0.001***
45.071 ± 15.604
43.853 ± 14.831
0.112
41.966 ± 13.144
41.354 ± 13.413
0.286
39.209 ± 11.843
36.751 ± 12.778
0.012**
C3(g/L)
1.027 ± 0.198
1.030 ± 0.196
0.814
1.025 ± 0.220
1.021 ± 0.183
0.670
1.021 ± 0.203
1.024 ± 0.186
0.758
1.031 ± 0.183
1.032 ± 0.175
0.954
C4(g/L)
0.243 ± 0.144
0.255 ± 0.142
0.224
0.252 ± 0.141
0.246 ± 0.138
0.324
0.248 ± 0.137
0.252 ± 0.137
0.469
0.245 ± 0.139
0.241 ± 0.134
0.695
IgA(g/L)
1.433 ± 0.720
1.408 ± 0.722
0.619
1.405 ± 0.739
1.391 ± 0.700
0.709
1.462 ± 0.719
1.443 ± 0.724
0.555
1.557 ± 0.750
1.577 ± 0.707
0.732
IgG(g/L)
10.443 ± 2.237
10.436 ± 2.271
0.967
10.304 ± 2.290
10.165 ± 2.416
0.235
10.393 ± 2.277
10.417 ± 2.234
0.808
10.452 ± 2.207
10.650 ± 2.264
0.257
IgE(IU/mL)
149.414 ± 86.725
148.166 ± 87.992
0.840
155.292 ± 130.971
147.866 ± 102.403
0.219
151.545 ± 134.349
150.814 ± 158.919
0.907
156.317 ± 139.988
155.264 ± 131.955
0.992
IgM(g/L)
1.25 ± 0.71
1.31 ± 0.75
0.209
1.265 ± 0.709
1.241 ± 0.722
0.518
1.251 ± 0.725
1.261 ± 0.734
0.743
1.218 ± 0.719
1.175 ± 0.700
0.442
*P < 0.10; **P < 0.05; ***P < 0.01
Subsequently, variables with P < 0.1 in chi-square and T test were included in the univariable logistics regression analysis. In the 0.5–2.99 years subgroup, anemia [OR = 0.275(0.132–0.573), P < 0.001], WBC[OR = 0.93(0.872–0.992), P = 0.028] and VitD [OR = 0.978(0.971–0.986), P < 0.001] were protective factor for anti-HBs expression, while age [OR = 2.476(1.932–3.172), P < 0.001] was risk factor. The probability of anti-HBs negative increased by 147.6% for each age. In the 3–5.99 years subgroup, sufficient zinc [OR = 0.713(0.551–0.923, P = 0.01)] was protective factor for anti-HBs expression, while age [OR = 1.151(1.028–1.289), P = 0.014] was risk factor. In the 6–11.99 years subgroup, no statistically significant influencing factors were obtained. In the 12–18 years subgroup, VitD [OR = 0.984(0.972–0.996), P = 0.01] was protect factor for anti-HBs expression (Table 3, Fig. 1A). The OR of age, WBC and VitD means each additional unit of these variables increases the probability of anti-HBs negative for (OR-1) × 100%. To further evaluate the distribution relationship between age and other measurement data, as well as the influence on anti-HBS expression, scatter plots and fitting lines were drawn using R language. Mean VitD levels were significantly higher in the anti-HBS positive group than negative group when age < 4 years (Fig. 1B). When it came to Hb, anti-HBs negative children under 2 years had higher hemoglobin level (Fig. 1C). There was no significant difference in the quantitative level of zinc among different age groups, as zinc was discussed as a categorical variable in univariate logistics analysis (Fig. 1D).
Table 3
Univariable logistic regression analyze results of four age subgroups
Variable
0.5 ~ 2.99 years(n = 1166)
3 ~ 5.99 years(n = 1680)
6 ~ 11.99 years(n = 2265)
12 ~ 18 years(n = 727)
OR(95%CI)
P value
OR(95%CI)
P value
OR(95%CI)
P value
OR(95%CI)
P value
Whether the children had a history of second-hand cigarette exposure
 No
0.891(0.650–1.221)
0.474
1.106(0.891–1.347)
0.361
0.844(0.699–1.019)
0.078*
0.971(0.693–1.361)
0.864
 Yesa
        
Anemia
 No
0.275(0.132–0.573)
< 0.001***
0.758(0.516–1.112)
0.156
0.838(0.603–1.166)
0.293
0.964(0.444–2.092)
0.927
 Yesa
        
Lead intoxication
 No
  
1.567(0.22–11.111)
0.645
0.204(0.025–1.634)
0.134
0.965(0.176–5.319)
0.968
 Yesa
        
Cadmium intoxication
 No
1.786(0.929–3.436)
0.082*
1.106(0.525–2.331)
0.79
1.225(0.732–2.409)
0.44
1.236(0.473–3.226)
0.666
 Yesa
        
Zinc deficiency
 No
0.786(0.580–1.065)
0.119
0.741(0.574–0.958)
0.022**
1.186(0.980–1.435)
0.079*
1.309(0.96–1.786)
0.089*
 Yesa
        
Copper deficiency
 No
0.873.(0.566–1.344)
0.536
1.235(0.978–1.56)
0.076*
1.073(0.892–1.292)
0.453
1.153(0.842–1.580)
0.375
 Yesa
        
Calcium deficiency
 No
1.812(0.330–9.901)
0.494
1.217(0.729–2.028)
0.454
0.958(0.796–1.152)
0.646
0.756(0.549–1.041)
0.087*
 Yesa
        
Iron deficiency
 No
0.789(0.596–1.043)
0.095*
0.925(0.755–1.134)
0.451
1.011(0.82–1.248)
0.915
1.111(0.589–2.096)
0.745
 Yesa
        
Age
2.476(1.932–3.172)
< 0.001***
1.151(1.028–1.288)
0.014**
0.971(0.923–1.021)
0.247
0.968(0.853–1.098)
0.609
WBC(10^9/L)
0.93(0.872–0.992)
0.028**
0.98(0.935–1.028)
0.405
0.993(0.949–1.038)
0.746
1.008(0.913–1.112)
0.882
VitD(ng/ml)
0.978(0.971–0.986)
< 0.001***
0.995(0.988–1.001)
0.112
0.997(0.99–1.003)
0.286
0.984(0.972–0.996)
0.010**
aReference group; *P < 0.10; **P < 0.05; ***P < 0.01
Then, variables with P < 0.1 in the univariable logistics regression analysis were included into multivariable logistics regression. Stepwise backward maximum likelihood method was applied to eliminate meaningless variables (αin = 0.05, αout = 0.10). Compare to univariate logistic, the WBC was excluded in multivariable logistics regression (Table 4).
Table 4
Multivariable logistics regression analyze results of four age subgroups
Variable
OR(95%CI)
P value
0.5 ~ 2.99 years(n= 1166)
Anemia
 No
0.392(0.185–0.835)
0.015*
 Yesa
  
Cadmium intoxication
 No
1.88(0.93–3.802)
0.079
 Yesa
  
Age
2.542(1.961–3.295)
< 0.001***
VitD(ng/ml)
0.977(0.969–0.984)
< 0.001***
3 ~ 5.99 years(n= 1680)
Zinc deficiency
 No
0.713(0.551–0.923)
0.01*
 Yesa
  
Copper deficiency
 No
1.264(0.998–1.6)
0.052
 Yesa
  
Age
1.151(1.028–1.289)
0.015*
6 ~ 11.99 years(n= 2265)
Whether the children had a history of second-hand cigarette exposure
 No
0.841(0.697–1.015)
0.072
 Yesa
  
Zinc deficiency
 No
0.84(0.695–1.016)
0.073
 Yesa
  
12 ~ 17.99 years(n= 727)
Zinc deficiency
 No
1.355(0.991–1.855)
0.057
 Yesa
  
VitD(ng/ml)
0.983(0.971–0.995)
0.007**
aReference group; *P < 0.05; **P < 0.01; ***P < 0.001

Discussion

This research studied potential factors that may affect the response level of hepatitis B immunization, ranging from exterior elements such as the way of birth and duration of the lactation period to biochemical factors in the children. Our study demonstrated that age or time since vaccination remains a major factor associated with anti-HBs expression, which was consistent with previous studies [8, 9]. In the 0.5–2.99 years subgroup and the 3–5.99 years subgroup, the risk of negative anti-HBS was significantly increased with age, while the 6–11.99 years subgroup and the 12–18 years subgroup didn’t.
In this report, we found anemia acted as a protective factor statistically for the anti-HBs in the 0.5–2.99 years subgroup, especially < 2 years. However, there are still controversial opinions about the immune response in anemia patients. An American study showed that the prevalence of iron deficiency (ID), anemia, and iron deficiency anemia (IDA) among children 1–2 years (12–35.9 months) was 13.5% (9.8, 17.2), 5.4% (3.5, 7.4), and 2.7% (1.2, 4.2) respectively [19], which demonstrated anemia was a common child health problem. Continued breastfeeding may increase IDA prevalence in 6-to-23 months children, and the associations of anemia with inflammation, zinc deficiency and infections could be suggesting the occurrence of nutritional immunity [20]. A study of Kenyan infants clarified that correction of iron deficiency may improve the response to diphtheria, pertussis, and pneumococcal vaccines during early infancy [21]. Further research is needed on the mechanism and effect of anemia on the response to hepatitis B vaccination.
In our study, vitamin D was a significantly protective factor for anti-HBs in the 0.5–2.99 years subgroup and the 12–18 years subgroup by quantitative logistics regression analysis. These two ages subgroup correspond to the two main growth peaks for children -- infancy and adolescence. In the scatter plot, the effect of vitamin D deficiency was most obvious in children < 4 years. Vit D might have a beneficial impact on the body’s immune system and modulate both innate and adaptive immunity [22], which is also supported by our study. A clinical study illustrated that serum concentrations of 25(OH)D affect the level of IL-6, TNF-α, and CRP. Children with status ≥75 nmol/L had a high level of IL-6, TNF-α, and CRP compared to the < 50 nmol/L and 50–74.9 nmol/L categories [23]. Based on above results, 75 nmol/L is recommended as an appropriate vitamin D serum concentration.
Zinc is essential for cellular processes in all cells, especial for cells with a rapid rate of turnovers such as those of the immune, gastrointestinal systems, and skin. These cells are particularly vulnerable to zinc deficiency [24]. Interestingly, this effect was statistically significant only in the 3–5.99 subgroup in our research. The effect of zinc on vaccination remains to be further studied.
In contrast with studies aimed at adults [15], no association was confirmed between immune response and second-hand cigarette exposure. In fact, the detrimental outcome of cigarettes on immunologic reaction demands long-term exposure to smoke. Children usually expose to less smoke for a shorter time, making the adverse effect of smoking more formidable to discover.
This study was a retrospective, cross-sectional, case-control study. There was a certain lag before the observation of the outcome (the point of negative anti-HBs appearance). Older children may turn anti-HBs negative prior to the test. Therefore, we cannot determine the exact time when their antibodies turned negative. Cohort studies were needed to further investigate the long-term effects of early nutritional deficiencies. At the beginning of the research, anti-HBS quantitative titration experiment was not included in the routine item of physical examination, so we didn’t acquire complete quantitative anti-HBS data in this study. As a result, we only discussed qualitative anti-HBS level. Furthermore, our study did not distinguish anti-HBs positive groups(> = 10mIU/ml) and anti-HBs high response group(> = 100Miu/ml). In addition, the subjects of the research were selected from the children participating in voluntary physical examinations in Hunan Province, leading to inevitable selective bias. Although explicit inclusion criteria were applied, there was still avoidless memory bias of subtle details when completing the telephone follow-up survey.

Conclusion

This study listed possible factors that might influence the response level to hepatitis B vaccines, providing a reference for both parents and health policy-makers. In the domain of efficient prevention of hepatitis, we recommended that parents should provide their children with healthy and balanced nutrition and sufficient Vit D, Zinc to maintain the quantity of antibodies, especially in the early neonatal period. In addition, enhancing the education of HBV infected mothers is a great way to block transmission of hepatitis B in children. Booster vaccination for children in high epidemic areas with anti-HBS turning negative is also a possible approach. Although this study found that anemia acted as a protective factor for anti-HBs in the 0.5–2.99 subgroup, there was no clear evidence that it was beneficial for the long-term maintenance of anti-HBs. We recommend that children with anemia should receive appropriate treatment as soon as possible to recover from anemia.

Acknowledgements

We thank all participants for their selfless and invaluable contribution.

Declarations

This study protocol was approved by the Ethics Committee of The Third Xiangya Hospital of Central South University. Written consent from participants or their primary caregiver was not necessary for this study, as it involved accessing medical records to retrospectively obtain children’s gender, age, and laboratory findings. During the telephone follow-up, we explained the purpose of the investigation, and obtain the consent of the respondents orally. After all information was collected, all participants were randomly assigned a unique id to anonymize.
Not applicable.

Competing interests

No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Hepatitis B. vaccines: WHO position paper - July 2017. Wkly Epidemiol Rec. 2017;92(27):369–92. Hepatitis B. vaccines: WHO position paper - July 2017. Wkly Epidemiol Rec. 2017;92(27):369–92.
2.
Zurück zum Zitat Wang H, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):811.CrossRef Wang H, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):811.CrossRef
3.
Zurück zum Zitat Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39–42.CrossRef Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39–42.CrossRef
4.
Zurück zum Zitat Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Front Med. 2020;14(1):21–9.CrossRef Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Front Med. 2020;14(1):21–9.CrossRef
5.
Zurück zum Zitat Liu J, et al. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230–8.CrossRef Liu J, et al. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(3):230–8.CrossRef
6.
Zurück zum Zitat Mast EE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1–31. Mast EE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1–31.
7.
Zurück zum Zitat Cui F, et al. Prevention of Chronic Hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72.CrossRef Cui F, et al. Prevention of Chronic Hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72.CrossRef
8.
Zurück zum Zitat Yue X, et al. Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: a hospital-based study. J Viral Hepat. 2018;25(4):373–80.CrossRef Yue X, et al. Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: a hospital-based study. J Viral Hepat. 2018;25(4):373–80.CrossRef
9.
Zurück zum Zitat He F, et al. The Serum Anti-HBs level among children who received routine hepatitis B vaccination during infancy in Mianyang City, China: a cross-sectional study. Viral Immunol. 2016;29(1):40–8.CrossRef He F, et al. The Serum Anti-HBs level among children who received routine hepatitis B vaccination during infancy in Mianyang City, China: a cross-sectional study. Viral Immunol. 2016;29(1):40–8.CrossRef
10.
Zurück zum Zitat Zhang W, et al. Maternal immunization promotes the immune response of neonates towards hepatitis B vaccine. J Viral Hepat. 2013;20(12):875–81.CrossRef Zhang W, et al. Maternal immunization promotes the immune response of neonates towards hepatitis B vaccine. J Viral Hepat. 2013;20(12):875–81.CrossRef
11.
Zurück zum Zitat Çekmez F, et al. Response to hepatitis B vaccine differs by birthweight among neonates. Vaccine. 2011;29(17):3096–7.CrossRef Çekmez F, et al. Response to hepatitis B vaccine differs by birthweight among neonates. Vaccine. 2011;29(17):3096–7.CrossRef
12.
Zurück zum Zitat Middleman AB, et al. The effect of late doses on the achievement of seroprotection and antibody titer levels with hepatitis b immunization among adolescents. Pediatrics (Evanston). 2001;107(5):1065.CrossRef Middleman AB, et al. The effect of late doses on the achievement of seroprotection and antibody titer levels with hepatitis b immunization among adolescents. Pediatrics (Evanston). 2001;107(5):1065.CrossRef
13.
Zurück zum Zitat Kang G, et al. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers. Vaccine. 2015;33(33):4093–9.CrossRef Kang G, et al. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers. Vaccine. 2015;33(33):4093–9.CrossRef
14.
Zurück zum Zitat Ertekin V, Selimoglu MA. Effects of several socio-demographic factors on hepatitis B immunization rates. Eur J Gastroenterol Hepatol. 2004;16(7):719.CrossRef Ertekin V, Selimoglu MA. Effects of several socio-demographic factors on hepatitis B immunization rates. Eur J Gastroenterol Hepatol. 2004;16(7):719.CrossRef
15.
Zurück zum Zitat Shaw FJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7(5):425–30.CrossRef Shaw FJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989;7(5):425–30.CrossRef
16.
Zurück zum Zitat Roome AJ, Walsh SJ, Cartter ML. Hepatitis B Vaccine Responsiveness in Connecticut Public Safety Personnel. JAMA. 1993;270(24):2931–4.CrossRef Roome AJ, Walsh SJ, Cartter ML. Hepatitis B Vaccine Responsiveness in Connecticut Public Safety Personnel. JAMA. 1993;270(24):2931–4.CrossRef
17.
Zurück zum Zitat Hollinger FB. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med. 1989;87(3A):36S.CrossRef Hollinger FB. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med. 1989;87(3A):36S.CrossRef
18.
Zurück zum Zitat Davey SG. Effect of passive smoking on health. BMJ. 2003;326(7398):1048–9.CrossRef Davey SG. Effect of passive smoking on health. BMJ. 2003;326(7398):1048–9.CrossRef
19.
Zurück zum Zitat Gupta P, et al. Iron, anemia, and iron deficiency anemia among young children in the United States. Nutrients. 2016;8(6):330.CrossRef Gupta P, et al. Iron, anemia, and iron deficiency anemia among young children in the United States. Nutrients. 2016;8(6):330.CrossRef
20.
Zurück zum Zitat Fançony C, et al. Iron deficiency anaemia among 6-to-36-month children from northern Angola. BMC Pediatr. 2020;20(1):298.CrossRef Fançony C, et al. Iron deficiency anaemia among 6-to-36-month children from northern Angola. BMC Pediatr. 2020;20(1):298.CrossRef
21.
Zurück zum Zitat Stoffel NU, et al. Iron deficiency anemia at time of vaccination predicts decreased vaccine response and iron supplementation at time of vaccination increases humoral vaccine response: a birth cohort study and a randomized trial follow-up study in Kenyan infants. Front Immunol. 2020;11:1313.CrossRef Stoffel NU, et al. Iron deficiency anemia at time of vaccination predicts decreased vaccine response and iron supplementation at time of vaccination increases humoral vaccine response: a birth cohort study and a randomized trial follow-up study in Kenyan infants. Front Immunol. 2020;11:1313.CrossRef
22.
Zurück zum Zitat Mailhot G, White JH. Vitamin D and immunity in infants and children. Nutrients. 2020;12(5):1233.CrossRef Mailhot G, White JH. Vitamin D and immunity in infants and children. Nutrients. 2020;12(5):1233.CrossRef
23.
Zurück zum Zitat Brett N, et al. Vitamin D Status and Immune Health Outcomes in a Cross-Sectional Study and a Randomized Trial of Healthy Young Children. Nutrients. 2018;10(6):680.CrossRef Brett N, et al. Vitamin D Status and Immune Health Outcomes in a Cross-Sectional Study and a Randomized Trial of Healthy Young Children. Nutrients. 2018;10(6):680.CrossRef
24.
Zurück zum Zitat Ackland ML, Michalczyk AA. Zinc and infant nutrition. Arch Biochem Biophys. 2016;611:51–7.CrossRef Ackland ML, Michalczyk AA. Zinc and infant nutrition. Arch Biochem Biophys. 2016;611:51–7.CrossRef
Metadaten
Titel
Evaluation of factors associated the expression of anti-HBs in children in Hunan Province, China
verfasst von
Shan Tan
Shizhou Li
Jianxiang Dong
Hongmei Dai
Minghua Yang
Fang Sun
Yang Yang
Jie Jiang
Shan Zhu
Mingyi Zhao
Zhiheng Chen
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Pediatrics / Ausgabe 1/2022
Elektronische ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03718-z

Weitere Artikel der Ausgabe 1/2022

BMC Pediatrics 1/2022 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.